软脑膜转移是非小细胞肺癌的罕见并发症且死亡率高,是由肿瘤细胞扩散到脑脊液腔引发,患者可能因此遭受失明、瘫痪和精神障碍,严重影响生活质量。四川大学华西医院肿瘤中心薛建新等发表于Lung Cancer的综述[1]阐述了软脑膜转移的潜在机制,探讨了...
TREATMENTLung CancerNon-Small Cell Lung CancerDIAGNOSISLung cancer is becoming the most common cancer globally. In China, Lung cancer has become prevalent among preceding compared to present smokers. There are many treatments for lung cancer globally like Chemotherapy, Radiotherapy, Surgery, and Targeted...
[5] Santos ES.Treatment options after first-line immunotherapy in metastatic NSCLC.Expert Rev Anticancer Ther.2020 Mar;20(3):221-228. [6] Datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced ...
[2]Zhong WZ,Chen KN,Chen C,et al.Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment ofStage IIIA-N2 EGFR-Mutant Non–Small-Cell Lung Cancer(EMERGING-CTONG 1103):ARandomized Phase II Study.J Clin Oncol.2019 Jun13:JCO1900075. [3]Yue Yang,et al.Lung Cancer.2023 Feb 17;178...
[1] David Pl, Nathalie C, Marie W, et al. ICARUS-LUNG01: A phase 2 study of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), with sequential tissue biopsies and biomarkers analysis to predict treatment outcome. 2024 ASCO....
Non-small-cell lung cancer is the most common type of lung cancer. It's serious, but treatment can sometimes cure it or stop it from getting worse. WebMD explains.
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screening of populations at risk with low-dose...
The paradigm of non-small cell lung cancer (NSCLC) treatment has been profoundly influenced by the development of immune checkpoint inhibitors (ICI), but the range of clinical responses observed among patients poses significant challenges. To date, analyses of tumor biopsies are the only parameter ...
News & Views20 Jan 2025Nature Cancer Volume: 6, P: 20-21 Related Subjects Non-small-cell lung cancer Small-cell lung cancer Latest Research and Reviews Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer ...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni